1 |
Kollipara R, Odhav A, Rentas KE, Rivard DC, Lowe LH, Dinneen L. Vascular anomalies in pediatric patients: updated classification, imaging, and therapy. Radiol Clin North Am; 51: 659-672, 2013. DOI: https://doi.org/10.1016/j.rcl.2013.04.002
DOI
|
2 |
Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol; 47: 106-117, 2012. DOI: https://doi.org/10.1053/j.ro.2011.11.002
DOI
|
3 |
Legiehn GM, Heran MK. A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations. Semin Intervent Radiol; 27: 209-231, 2010. DOI: https://doi.org/10.1055/s-0030-1253521
DOI
|
4 |
Donnelly LF, Adams DM, Bisset GS 3rd. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol; 174: 597-608, 2000. DOI: https://doi.org/10.2214/ajr.174.3.1740597
DOI
|
5 |
Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol; 141: 483-488, 1983. DOI: https://doi.org/10.2214/ajr.141.3.483
DOI
|
6 |
Alomari A, Dubois J. Interventional management of vascular malformations. Tech Vasc Interv Radiol; 14: 22-31, 2011. DOI: https://doi.org/10.1053/j.tvir.2010.07.006
DOI
|
7 |
Guevara CJ, Alomari AI. Interdisciplinary approach to treatment of vascular anomalies. Tech Vasc Interv Radiol; 16: 55-58, 2013. DOI: https://doi.org/10.1053/j.tvir.2013.01.008
DOI
|
8 |
Murata S, Mine T, Sugihara F, Yasui D, Yamagu-chi H, Ueda T, Onozawa S, Kumita S. Interven-tional treatment for unresectable hepatocellu-lar carcinoma. World J Gastroenterol; 20: 13453-65, 2014. DOI: https://doi.org/10.3748/wjg.v20.i37.13453
DOI
|
9 |
Saraswat VA, Pandey G, Shetty S. Treatment algorithms for managing hepatocellular carci-noma. J Clin Exp Hepatol ; 4 Suppl 3: S80-9, 2014. DOI: https://doi.org/10.1016/j.jceh.2014.05.004
DOI
|
10 |
Chen D, Wang R, Meng X, Yan H, Jiang S, Feng R, Zhu K, Xu X, Dou X, Jin L. Prognostic value of serum gamma- glutamyl transferase in unre-sectable hepatocellular carcinoma patients treated with transcatheter arterial chemoem-bolization combined with conformal radiotherapy. Oncol Lett; 8: 2298-304, 2014. DOI: https://doi.org/10.1016/j.jceh.2014.05.004
DOI
|
11 |
Ngan H, Peh WC. Arteriovenous Shunting in Hepatocellular Carcinoma: Its Prevalence and Clinical Significance. Clin Radiol ; 52: 36-40, 1997. DOI: https://doi.org/10.1016/S0009-9260(97)80303-0
DOI
|
12 |
DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology ; 49: 1729-1764, 2009. DOI: https://doi.org/10.1002/hep.22772
DOI
|
13 |
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet ; 362: 1907-17, 2003. DOI: https://doi.org/10.1016/S0140-6736(03)14964-1
DOI
|
14 |
Kumar A, Ahuja CK, Vyas S, Kalra N, Khandel-wal N, Chawla Y, Dhiman RK. Hepatic arterio-venous fistulae: role of interventional radiolo-gy. Dig Dis Sci; 57: 2703-12, 2012. DOI: https://doi.org/10.1007/s10620-012-2331-0
DOI
|
15 |
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg; 69: 412-422, 1982.
DOI
|